YD Bio Revenue

In the year 2024, YD Bio had annual revenue of $510.36K with 45.76% growth. YD Bio had revenue of $142.69K in the quarter ending December 31, 2024, with 95.63% growth.

Revenue (ttm)

$510.36K

Revenue Growth

+45.76%

P/S Ratio

25.30

Revenue / Employee

n/a

Employees

n/a

Market Cap

806.22M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	510.36K	160.23K	45.76%
Dec 31, 2023	350.13K	-13.99K	-3.84%
Dec 31, 2022	364.12K	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

YDES News

9 days ago - YD Bio Enters into MOU to Merge with EG BioMed, Advancing DNA Methylation–Driven AI Platforms for Cancer Diagnostics and Drug Development - GlobeNewsWire
10 days ago - YD Bio Limited Announces Major Milestones and Unveils Robust 2026 Clinical and Commercial Roadmap - GlobeNewsWire
4 weeks ago - YD Bio Limited Expands U.S. Presence with Newly Planned California Facilities and Operations Center - GlobeNewsWire
5 weeks ago - YD Bio Limited Showcases Its Innovative Diagnostic and Precision Medicine Portfolios at the 9th Healthcare EXPO TAIWAN - GlobeNewsWire
6 weeks ago - YD Bio Limited Expands OkaiDx™ Testing Portfolio to Pancreatic and Colorectal Cancer Detection Across the U.S. and Provides Clinical Research Update on Pancreatic Cancer Early Detection - GlobeNewsWire
7 weeks ago - YD Bio Limited Announces U.S. Ophthalmology Market Entry, Advances Across Diagnostics and LSC Exosome Therapeutics - GlobeNewsWire
2 months ago - YD Bio and EG BioMed Expand U.S. Access to OkaiDx™, a cfDNA‑Methylation Blood Test for Post‑Treatment Breast Cancer Monitoring - GlobeNewsWire
3 months ago - YD Bio Ltd. Rings Nasdaq Opening Bell to Celebrate Listing under Ticker YDES - GlobeNewsWire

More News